uniQure NV (QURE)
22.69
-0.02
(-0.11%)
USD |
NASDAQ |
Oct 21, 16:00
24.06
+1.37
(+6.04%)
Pre-Market: 08:14
uniQure Net Income (Quarterly) : -81.06M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -81.06M |
| March 31, 2026 | -53.54M |
| December 31, 2025 | -37.09M |
| September 30, 2025 | -80.53M |
| June 30, 2025 | -37.72M |
| March 31, 2025 | -43.64M |
| December 31, 2024 | -73.26M |
| September 30, 2024 | -44.38M |
| June 30, 2024 | -56.30M |
| March 31, 2024 | -65.62M |
| December 31, 2023 | -73.21M |
| September 30, 2023 | -89.57M |
| June 30, 2023 | -68.47M |
| March 31, 2023 | -77.23M |
| December 31, 2022 | 6.807M |
| September 30, 2022 | -47.86M |
| June 30, 2022 | -39.06M |
| March 31, 2022 | -46.68M |
| December 31, 2021 | 8.208M |
| September 30, 2021 | -36.53M |
| June 30, 2021 | 399.47M |
| March 31, 2021 | -41.56M |
| December 31, 2020 | -0.699M |
| September 30, 2020 | -53.78M |
| June 30, 2020 | -42.55M |
| Date | Value |
|---|---|
| March 31, 2020 | -28.00M |
| December 31, 2019 | -41.43M |
| September 30, 2019 | -23.60M |
| June 30, 2019 | -31.40M |
| March 31, 2019 | -27.77M |
| December 31, 2018 | -21.89M |
| September 30, 2018 | -22.04M |
| June 30, 2018 | -20.59M |
| March 31, 2018 | -18.79M |
| December 31, 2017 | -27.47M |
| September 30, 2017 | -10.24M |
| June 30, 2017 | -21.27M |
| March 31, 2017 | -20.27M |
| December 31, 2016 | |
| September 30, 2016 | -15.27M |
| June 30, 2016 | -21.83M |
| March 31, 2016 | -24.58M |
| December 31, 2015 | -15.44M |
| September 30, 2015 | -28.73M |
| June 30, 2015 | -20.89M |
| March 31, 2015 | -14.21M |
| December 31, 2014 | -13.94M |
| September 30, 2014 | -12.00M |
| June 30, 2014 | -12.33M |
| March 31, 2014 | -10.73M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Kymera Therapeutics, Inc. | -61.21M |
| Moderna, Inc. | -782.00M |
| Abivax SA | -136.54M |
| GRAIL, Inc. | -110.25M |
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 5.841M |
| Total Expenses (Quarterly) | 86.90M |
| EPS Diluted (Quarterly) | -1.224 |
| Enterprise Value | 1.315B |
| Gross Profit Margin (Quarterly) | 10.00% |
| Profit Margin (Quarterly) | -1.39K% |
| Earnings Yield | -17.84% |
| Normalized Earnings Yield | -17.70 |